Abstract: There is provided a phase shifter having a phase shift region and a peripheral region, and including a first substrate, a second substrate and a dielectric layer between such two substrates; the first substrate includes a first dielectric substrate, a first electrode and a first auxiliary structure; the second substrate includes a second dielectric substrate, a second electrode and a second auxiliary structure; the phase shift region includes overlapping regions; the first electrode and the second electrode are located in the phase shift region, and have orthographic projections, on the first dielectric substrate, overlapped at least partially in the overlapping regions; the first auxiliary structure is in the peripheral region and on a side, close to the dielectric layer, of the first dielectric substrate; the second auxiliary structure is in the peripheral region and on a side, close to the dielectric layer, of the second dielectric substrate.

Abstract: A display device includes a substrate, a pixel array and a first scan driver. The pixel array is formed on the substrate. The pixel array includes multiple gate lines and multiple connection lines. The gate lines extend along a first direction. The connection lines extend along a second direction different from the first direction. The first scan driver includes multiple dummy stages and a first stage to a last stage. The dummy stages and the first stage to the last stage of the first scan driver are arranged in sequence along a direction the same as a signal transmission direction on the substrate.

Abstract: A construction method for a radiation-proof concrete hole reserved split bolt includes: 1) mounting a hole reserved sleeve; 2) mounting an inclined recoverable split bolt; 3) mounting an inclined split bolt; 4) fixing the inclined recoverable split bolt and an inclined split bolt main body; 5) pouring concrete, and dismantling related components; 6) plugging the inclined split bolt main body; and 7) plugging the hole reserved sleeve. According to the construction method, the hole reserved sleeve is obliquely arranged, the inner side of the hole reserved sleeve is sprayed with a radiation-proof coating with the functions of reducing radiation ray reflection and absorbing certain radiation rays, and in addition, after the construction of a pipeline or a line in the hole reserved sleeve is finished, the openings at both ends of the hole reserved sleeve are plugged with a radiation-proof mortar incorporated with a micro-expanding agent and a waterproof agent.

Abstract: The present invention provides a target sequence of an RNA virus. The target sequence is a nucleic acid sequence fragment in the gene sequence in the RNA virus containing 20-40 bases and having not less than 95% similarity to genome sequence of human or related species such as livestock and poultry. The above-mentioned target sequence of the RNA virus is selected from SEQ ID NO. 1-SEQ ID NO. 615. The present invention also relates to a primer composition for constructing the above-mentioned target sequence, biomaterials such as antisense RNA related to the above-mentioned target sequence, and related uses such as design of a vaccine lacking the target sequence. The virus fragment with the above-mentioned sequence constructed in the present invention has the function of interacting with human genomic DNA and is similar to viral miRNA.

Abstract: A method of forming a semiconductor device includes: forming a semiconductor structure having source/drain regions, a fin disposed between the source/drain regions, and a dummy gate disposed on the fin and surrounded by a spacer; removing the dummy gate to form a gate trench which is defined by a trench-defining wall; forming a gate dielectric layer on the trench-defining wall; forming a work function structure on the gate dielectric layer; forming a resist layer to fill the gate trench; removing a top portion of the resist layer; removing the work function structure exposed from the resist layer using a wet chemical etchant; removing the resist layer; and forming a conductive gate in the gate trench.

Abstract: A vehicle air conditioning system includes a first passenger compartment heating loop and a first battery pack heat exchange loop. The first passenger compartment heating loop and the first battery pack heat exchange loop share a compressor and an out-vehicle condenser. The first passenger compartment heating loop further includes an in-vehicle condenser, the first battery pack heat exchange loop further includes a heat conducting component connected to a power battery. The power battery is connected to a self-heating circuit used for self-heating the power battery; and an outlet of the compressor is in communication with an inlet of the in-vehicle condenser. An outlet of the in-vehicle condenser is in communication with an inlet of the out-vehicle condenser, and an outlet of the out-vehicle condenser is in communication with an inlet of the compressor.

Abstract: The use of Bifidobacterium lactis BL-99 in the prevention and/or amelioration of gastritis. The present invention provides the use of Bifidobacterium lactis in the preparation of a composition for preventing and/or ameliorating gastritis, wherein the Bifidobacterium lactis is Bifidobacterium lactis having the deposit number of CGMCC No. 15650. The Bifidobacterium lactis can prevent and/or ameliorate chronic gastritis, and/or prevent and/or ameliorate gastric mucosal atrophy associated with gastritis.

Abstract: The present disclosure discloses a method for reducing the fructan content in food made of rice and flour using microwave heating and belongs to the technical field of food processing. Fermented products made of rice and flour are prepared using microwave heating and fructan in the products can be effectively degraded. Compared with traditional steaming, the method can remarkably reduce the fructan content in the fermented food, effectively alleviate the bowel stress sensitivity to the fermented rice and flour food by patients with irritable bowel syndrome (IBS), meet the daily dietary requirements of special crowds, has the advantages of simple process, green processing and environmental protection, and is suitable for large-scale industrial production.

Abstract: Disclosed is the use of a Bifidobacterium longum subsp. infantis strain in the preparation of a composition for anti-aging in individuals, improving innate immunity in individuals, relieving symptoms caused by Staphylococcus aureus infections in individuals and/or inhibiting Staphylococcus aureus infection in individuals, wherein the Bifidobacterium infantis is Bifidobacterium infantis with the deposit number of CGMCC NO. 21109. A composition for anti-aging in individuals, improving innate immunity in individuals, relieving symptoms caused by Staphylococcus aureus infections in individuals and/or inhibiting Staphylococcus aureus infection in individuals.

Abstract: Disclosed is the use of Bifidobacterium lactis BL-99 in the protection of cartilage. Provided in the present invention is the use of Bifidobacterium lactis in the preparation of a composition for protecting cartilage, wherein the Bifidobacterium lactis is Bifidobacterium lactis with the deposit number of CGMCC No. 15650. The Bifidobacterium lactis can promote the development of cartilage, increase cartilage density, protect cartilage from damage, promote cartilage repair and/or ameliorate cartilage damage, and is beneficial to cartilage health.

Abstract: An authority management method. The method is applied to a first terminal device, and includes: sending a first authority application request to an authority management device, the first authority application request being configured to apply for a first authority, the first authority being an authority that is desired to be obtained by the first terminal device, and the first authority being a task authority for an execution device; and receiving a first authorization information block sent by the authority management device, the first authorization information block including first authorization information encrypted by a first private key, the first authorization information including description information for the first authority, the first private key being a key matching a first public key, and the first public key is stored in the execution device.

Abstract: The present disclosure provides the use of Lactobacillus paracasei subsp. paracasei K56 in enhancing resistance of the intestinal tract to bacterial infection and improving intestinal immunity. Particularly, the present disclosure provides the use of a Lactobacillus paracasei subsp. paracasei in the preparation of a composition for improving intestinal immunity, wherein the Lactobacillus paracasei subsp. paracasei has a deposit number of CGMCC 15139 or DSM 27447. The present inventors have discovered that this bacteria strain alone can significantly improve the resistance of the intestinal tract to bacterial infection, combat invasion by pathogenic bacteria in the intestinal system, maintain the intestinal barrier function, and/or prevent diarrhea caused by pathogenic bacteria.

Abstract: The present disclosure provides the use of Lactobacillus paracasei ET-22 in enhancing resistance of the intestinal tract to bacterial infection and improving intestinal immunity. Particularly, the present disclosure provides the use of a Lactobacillus paracasei in the preparation of a composition for improving intestinal immunity, wherein the Lactobacillus paracasei has a deposit number of CGMCC 15077. The present inventors have discovered that this bacteria strain alone can significantly improve the resistance of the intestinal tract to bacterial infection, combat invasion by pathogenic bacteria in the intestinal system, maintain the intestinal barrier function, and/or prevent diarrhea caused by pathogenic bacteria.

Abstract: A Bifidobacterium lactis BL-99 strain capable of enhancing immunity and the use thereof, which belongs to the technical field of microorganisms, is described. The Bifidobacterium lactis BL-99 provided by the present invention is deposited in China General Microbiological Culture Collection Center CGMCC on Apr. 26, 2018 with the deposit number CGMCC No. 15650. The bacteria have gastric acid resistance and intestinal fluid resistance, can significantly promote the growth of Bifidobacterium and Lactobacillus, significantly increase antibody-producing cells and half hemolysis value HC50, activate NK cell activity, and can be used to prepare foods for immunity enhancement. It also has the effects in preventing osteoporosis, increasing blood calcium and/or phosphorus ions, which has a wide range of application prospects.

Abstract: A Bifidobacterium lactis BL-99 strain capable of enhancing immunity and the use thereof, which belongs to the technical field of microorganisms, is described. The Bifidobacterium lactis BL-99 provided by the present invention is deposited in China General Microbiological Culture Collection Center CGMCC on Apr. 26, 2018 with the deposit number CGMCC No. 15650. The bacteria have gastric acid resistance and intestinal fluid resistance, can significantly promote the growth of Bifidobacterium and Lactobacillus, significantly increase antibody-producing cells and half hemolysis value HC50, activate NK cell activity, and can be used to prepare foods for immunity enhancement. It also has the effects in preventing osteoporosis, increasing blood calcium and/or phosphorus ions, which has a wide range of application prospects.

Abstract: The present disclosure provides novel uses of Bifidobacterium lactis BL-99 in anti-aging and improving innate immunity. The Bifidobacterium lactis strain according to the present disclosure has a deposit number of CGMCC 15650. It is discovered in the present disclosure that this strain alone has an anti-aging effect, is capable of improving innate immunity of an organism, and is capable of enhancing resistance of an organism to Staphylococcus aureus infection, thereby providing use of the Bifidobacterium lactis strain of deposit number CGMCC 15650 in preparation of a composition having an anti-aging effect, capable of improving innate immunity of an organism, and/or capable of enhancing resistance of an organism to Staphylococcus aureus infection.

Abstract: Semiconductor structures and methods for forming the same are provided. The method includes forming a dummy gate structure over a substrate and forming a sealing layer surrounding the dummy gate structure. The method includes forming a spacer covering the sealing layer and removing the dummy gate structure to form a trench. The method further includes forming an interfacial layer and a gate dielectric layer. The method further includes forming a capping layer over the gate dielectric layer and partially oxidizing the capping layer to form a capping oxide layer. The method further includes forming a work function metal layer over the capping oxide layer and forming a gate electrode layer over the work function metal layer. In addition, a bottom surface of the capping oxide layer is higher than a bottom surface of the spacer.

Abstract: A semiconductor device includes a source/drain portion, a metal silicide layer disposed over the source/drain portion, and a transition layer disposed between the source/drain portion and the metal silicide layer. The transition layer includes implantation elements, and an atomic concentration of the implantation elements in the transition layer is higher than that in each of the source/drain portion and the metal silicide layer so as to reduce a contact resistance between the source/drain portion and the metal silicide layer. Methods for manufacturing the semiconductor device are also disclosed.

Abstract: A new use of Lactobacillus paracasei subsp. paracasei K56 capable of regulating the gastrointestinal flora balance is described. The deposit number of the Lactobacillus paracasei subsp. paracasei is DSM27447. This strain alone has the ability to significantly promote the growth of intestinal Bifidobacterium and Lactobacillus, suppress Desulfovibrio and/or Enterobacteria in the intestine, suppress Helicobacter and/or Escherichia-Shigella, and can endure a simulated in vitro gastrointestinal fluid stress environment. Experiments in mice show that this strain has no acute oral toxicity, no antibiotic resistance, and may be safely used in food processing.

Abstract: The present invention provides novel use of Lactobacillus paracasei subsp. paracasei K56 in alleviation of intestinal inflammation. Lactobacillus paracasei subsp. paracasei K56 of the present invention has the deposit number CGMCC 15139 or DSM 27447. It was discovered in the present invention that the strain alone was highly efficacious at alleviating intestinal inflammation, reducing inflammatory factors IL-6 and/or TNF-?, promoting the anti-inflammatory factor IL-10, and reducing the tissue damage of colitis.